
No data
No data
No data
| CAS Number | 112811-59-3 |
| Catalog Number | AG001VAA(AGN-PC-0BS7RF) |
| Chemical Name | 1-Cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylicacid |
| IUPAC Name | 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
| InChI | InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26) |
| InChI Key | XUBOMFCQGDBHNK-UHFFFAOYSA-N |
| MDL Number | MFCD07368033 |
| Molecular Formula | C19H22FN3O4 |
| Molecular Weight | 375.3941 |
| NSC Number | 758701 |
| SMILES | O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CC(C)NCC4)=C3OC)C1=O)O |
| Synonyms | 1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,
AM 1155,
AM-1155,
BMS 206584,
BMS-206584,
BMS206584,
CG 5501,
gatifloxacin,
gatifloxacine,
Tequin,
Zymar,
Gatifloxacin,
112811-59-3,
Tequin,
Zymar,
Gatiflo,
AM-1155,
Gatifloxacine,
Gatiquin,
Gatispan,
Gatilox,
Zymaxid,
Gaity,
AM 1155,
CG 5501,
BMS-206584,
Gatifloxacin [USAN:INN],
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,
BMS 206584-01,
gatifloxacino,
gatifloxacinum,
1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
PD 135432,
CHEMBL31,
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-,
CHEBI:5280,
CG5501,
Gatifloxacin, 98%,
(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,
160738-57-8,
gatifloxin,
NCGC00068236-02,
CPD000043336,
G-2380,
DSSTox_CID_25704,
DSSTox_RID_81076,
DSSTox_GSID_45704,
1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
Bonoq,
Tymer,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid,
1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid,
SMR000043336,
Gatifloxacin (TN),
Gatifloxacin (INN),
GTFX,
gatifloxacin anhydrous,
CAS-112811-59-3,
Zymer (TN),
1-cyclopropyl-6-fluoro-8-methoxy-7-,
SR-01000610458,
(3-methylpiperazin-1-yl)-4-oxo-1,4-,
Gatifloxcin,
Tequin in dextrose 5% in plastic container,
AM-1155 (*Sesquihydrate*),
Gatifloxacin & Gamma Interferon,
Tequin and Zymar,
Gatifloxacin,(S),
CG-5501,
Kinome_3137,
PubChem21048,
Spectrum_001909,
PD135432,
BMS-206584-01,
PD-135432,
Gatiflo,Tequin and Zymar,
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-piperazin-1-yl)- 4-oxo-1,4-dihydro-quinoline-3-carboxylic acid,
Spectrum2_000487,
Spectrum3_000999,
Spectrum4_001127,
Spectrum5_001468,
SCHEMBL22591,
BSPBio_002697,
KBioGR_001613,
KBioSS_002448,
MLS000040259,
MLS000759493,
MLS006011836,
SPECTRUM1504272,
SPBio_000353,
Gatifloxacin Sesquihydrate,(S),
AC1L1K82,
DTXSID5045704,
CTK6J4376,
KBio2_002442,
KBio2_005010,
KBio2_007578,
KBio3_001917,
KS-00000IXR,
XUBOMFCQGDBHNK-UHFFFAOYSA-N,
HMS1922J15,
HMS2090K10,
HMS2093G06,
HMS2233D20,
HMS3259P06,
HMS3372J10,
HMS3372J12,
HMS3715N03,
Pharmakon1600-01504272,
ALBB-028535,
BCP13408,
RKL10068,
ZX-AN079351,
ZX-AP010622,
Tox21_110984,
BBL010485,
BDBM50117914,
BG0576,
CCG-39529,
MFCD00895399,
NSC758701,
s1340,
STK801620,
AKOS004119932,
AKOS016340697,
Tox21_110984_1,
AC-1944,
API0002807,
CS-1841,
DB01044,
KS-1066,
MCULE-4557972261,
NC00702,
NSC-758701,
RTR-002479,
VA11838,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,
NCGC00068236-03,
NCGC00068236-04,
NCGC00068236-05,
NCGC00068236-06,
NCGC00068236-07,
NCGC00068236-08,
NCGC00095126-01,
NCGC00095126-02,
NCGC00178525-01,
AK323595,
AN-14480,
AN-30562,
AN-31062,
BC204030,
CC-34682,
HY-10581,
SAM001246715,
SAM002589955,
SC-12171,
SBI-0206764.P001,
AB0012064,
AB1009302,
AB2000056,
AX8018671,
DB-019145,
LS-184402,
TL8001438,
TR-002479,
FT-0082686,
FT-0626635,
FT-0631189,
G0325,
C07661,
D08011,
AB00171654-13,
AB00171654-14,
AB00171654_16,
AB00171654_17,
811G593,
A802657,
C-21242,
Gatifloxacin, Antibiotic for Culture Media Use Only,
SR-01000610458-2,
SR-01000610458-3,
BRD-A74980173-001-02-8,
BRD-A74980173-001-06-9,
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-,
1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid,
1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid,
1-cyclopropyl-6-fluoranyl-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxidanylidene-quinoline-3-carboxylic acid,
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid,
1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid,
3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-,
sesquihydrate,
Zymer,
Quinolone der.,
Gatifloxacin hydrate,
Gatiflo (TN),
Tequin (TN),
Zymar (TN),
gatifloxacin hydrochloride,
Gatifloxacin sesquihydrate,
D03CQE,
UNII-81485Y3A9A,
CID5379,
dihydroquinoline-3-carboxylic acid,
BMS206584,
C19-H22-F-N3-O4,
81485Y3A9A,
ACN-038330,
BMS 206584,
CS-O-11656,
Gatiflo,Tequin and Zymar, Gatifloxacin,
Gatifloxacin, 99% - 100MG 100mg,
A1313,
180200-66-2,
C078049,
D000077734,
GAT,
|
| Complexity | 653 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 375.159g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 27 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 375.4g/mol |
| Monoisotopic Mass | 375.159g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 82.1A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.7 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

